title: Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice.
abstract: Activation of complement is one of the earliest immune responses to exogenous threats, resulting in various cleavage products including anaphylatoxin C3a. In addition to its contribution to host defense, C3a has been shown to mediate Th2 responses in animal models of asthma. However, the role of C3a on pulmonary Th17 responses during allergic inflammation remains unclear. Here, we show that mice deficient in C3a receptor (C3aR) exhibited (i) higher percentages of endogenous IL-17-producing CD4(+) T cells in the lungs, (ii) higher amounts of IL-17 in the bronchoalveolar lavage fluid, and (iii) more neutrophils in the lungs than wild-type mice when challenged with intranasal allergens. Moreover, adoptive transfer experiments showed that the frequencies of antigen-specific IL-17-producing CD4(+) T cells were significantly higher in the lungs and bronchial lymph nodes of C3aR-deficient recipients than those of wild-types recipients. Bone-marrow reconstitution study indicated that C3aR-deficiency on hematopoietic cells was required for the increased Th17 responses. Furthermore, C3aR-deficient mice exhibited increased percentages of Foxp3(+) regulatory T cells; however, depletion of these cells minimally affected the induction of antigen-specific Th17 cell population in the lungs. Neutralization of IL-17 significantly reduced the number of neutrophils in bronchoalveolar lavage fluid of C3aR-deficient mice. Our findings demonstrate that C3a signals negatively regulate antigen-specific Th17 responses during allergic lung inflammation and the size of Foxp3(+) regulatory T cell population in the periphery.
authors.affiliation: Center for Immunology and Autoimmune Diseases, Institute of Molecular Medicine, the University of Texas Medical School at Houston, TX, USA.
authors.forename: Hoyong
authors.initials: H
authors.lastname: Lim
authors.forename: Young Uk
authors.initials: YU
authors.lastname: Kim
authors.forename: Scott M
authors.initials: SM
authors.lastname: Drouin
authors.forename: Stacey
authors.initials: S
authors.lastname: Mueller-Ortiz
authors.forename: Kyoungah
authors.initials: K
authors.lastname: Yun
authors.forename: Eva
authors.initials: E
authors.lastname: Morschl
authors.forename: Rick A
authors.initials: RA
authors.lastname: Wetsel
authors.forename: Yeonseok
authors.initials: Y
authors.lastname: Chung
mesh_terms: D000485:Allergens / Q000008:administration & dosage / Q000276:immunology; D000706:Anaphylatoxins / Q000276:immunology*; D000818:Animals; D015926:Complement C3a / Q000276:immunology* / Q000378:metabolism; D004195:Disease Models, Animal; D051858:Forkhead Transcription Factors / Q000378:metabolism; D006967:Hypersensitivity / Q000276:immunology* / Q000378:metabolism; D020381:Interleukin-17 / Q000096:biosynthesis; D051379:Mice; D018345:Mice, Knockout; D020556:Neutrophil Infiltration / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D011014:Pneumonia / Q000235:genetics / Q000276:immunology*; D011951:Receptors, Complement / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D015398:Signal Transduction; D050378:T-Lymphocytes, Regulatory / Q000276:immunology / Q000378:metabolism; D058504:Th17 Cells / Q000276:immunology*
chemical_list: D000485:Allergens; D000706:Anaphylatoxins; D051858:Forkhead Transcription Factors; C498833:Foxp3 protein, mouse; D020381:Interleukin-17; D011951:Receptors, Complement; C085567:complement C3a receptor; D015926:Complement C3a